air max tn 8 Aarkstore Enterprise- cheap AirMax 20

manv1jdcgh

NHS England

Hospital Formularies
Collaborative Procurement Hubs
Public Procurement Directive

Table of Contents :
Executive Summary
1. Market Background
1.1 UK
1.2 National Health Service
lic hospitals represent a very important market segment for most biopharmaceutical companies in Europe. They are the often the only market for the increasing numbers of speciality drugs emerging from R&D, with many primary care products also unable to get established for maintenance therapy in the community without hospital recommendation first. Though the processes for achieving hospital usage are very different to the reimbursed GP/community pharmacy sector, they have been poorly documented and often little understood. This justpharmareports publication aims to clarify the situation for the UK, a particularly challenging country with four different public healthcare systems, numerous stakeholders, regular reforms, and rigorous health technology assessment.
Medicines prescribed in English hospitals in 2006 were valued at 2.7 billion. This represented 24% of the English NHS drugs bill (hospital prescribing in London alone accounted for 40% of all prescribing costs in the capital). Even more significantly, the hospital drug bill has been rising at more than twice the rate of GP prescribing costs.
Access to Hospital Pharmaceutical Markets in the UK provides:
Comprehensive and clear information on how medicines for hospital use get selected, purchased, distributed, prescribed, dispensed and paid for.
Separate sections on England, Scotland [link widoczny dla zalogowanych], Wales and Northern Ireland.
Full coverage of the NHS plus two of the largest private providers.
Explanation of tendering, contracting [link widoczny dla zalogowanych], contract adjudication and other aspects of procurement for both brands and generics.
Clarification of the complex English funding system, Payment by Results.
Special focus on oncology.
What discounts hospitals expect and why value-added tax is a concern.
Features on risk-sharing schemes and on the boom in homecare services.
NICE, SMC, AWMSG, the PPRS and much [link widoczny dla zalogowanych], much more

Uptake

Area Formularies
2.3 Health Technology Assessment
Case Study: Anticancers
2.2 Formularies

Clinical Guidelines

Scotland: SMC

NHS Wales
NHS Scotland
England: NICE
London Procurement Programme
3.3 Procurement in Scotland
3.4 Procurement in Wales
3.5 Procurement in Northern Ireland
3.6 Strategic Implications
For more information please contact :
/reports/Access-to-Hospital-Pharmaceutical-Markets-in-the-United-Kingdom-1052.html
/
From:Aarkstore Enterprise
Contact: Neel
Email: [link widoczny dla zalogowanych]
URL:
Pharmaceutical Market Support Group

Technology Appraisal Process
Manufacturer Submission

Prescribing

Northern Ireland
2.4 Strategic Implications
3. Procurement
3.1 Product Differentiation
3.2 Procurement in England

Contracting Process
Good Practice Guide for Contracting

NHS Bodies Concerned
Outcome

NHS Purchasing and Supply Agency

NHS Northern Ireland
1.3 NHS Funding
1.4 Pharmaceutical Use

Appeals
Costs
1.5 Strategic Implications
2. Managed Entry of New Drugs
2.1 Horizon Scanning

NHS Supply Chain

National Pharmaceutical Supplies Group

Topic Selection
Wales: AWMSG

DoH Commercial Directorate